Robert Michael Dudley
Board Member
Transcode Therapeutics, Inc. (RNAZ)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2016-01-01–present
-
2016-01-01–2024-01-13
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Transcode Therapeutics, Inc. (RNAZ) | Former Chief Executive Officer | $85,432 | $85,432 |
| 2023 | Transcode Therapeutics, Inc. (RNAZ) | Former Chief Executive Officer | $474,392 | $642,766 |
| 2022 | Transcode Therapeutics, Inc. (RNAZ) | Former Chief Executive Officer | $494,000 | $805,027 |
| 2021 | Transcode Therapeutics, Inc. (RNAZ) | Chief Executive Officer | $240,000 | $495,484 |
| 2020 | Transcode Therapeutics, Inc. (RNAZ) | Chief Executive Officer | — | $42,978 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.